ISA panel: Corporate governance code needed

After a trial period of 1 or 2 years, the code could be made obligatory.

By SHARON WROBEL
January 5, 2006 06:50
2 minute read.

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

A committee of the Israel Securities Authority on Wednesday recommended implementation of a corporate governance code in Israel aimed at preventing accounting scandals and integrating Israel into the global market. "The code puts in place procedures to provide investors with greater confidence and transparency," said Moshe Terry, chairman of the ISA. "The added level of compliance can reflect directly in the share price of the company, the liquidity of its stock and the cost of capital." The Goshen Committee, which is responsible for formulating a corporate governance code for Israeli publicly traded companies, published its recommendations stipulating changes to the structure of the board of directors, improved disclosure of financial information and establishment of a securities and corporate court. "Company laws in Israel are good but not effectively executed. Israeli court houses lack the experience and knowledge in the field," said Professor Zohar Goshen, chairman of the committee, which was set up about a year ago. Noga Kainan, president of the Israeli Forum of Chief Financial Officers, which represents 500 leading Israeli companies said the most important recommendation was the request for a corporate court. "We need a legal entity, which has the professional understanding for corporate issues," she said. Publicly traded companies initially will be requested to adapt the corporate governance code on a voluntary basis but Kainan believes it could still prove effective. "Although the code might be voluntary, it might still force companies to comply, as non-compliance might suggest that you are trying to hide something," said Kainan. After a trial period of 1 or 2 years, the code could be made obligatory. "Following the recent big accounting scandals such as Enron or Worldcom, global markets have seen the need to implement corporate governance rules. Israel must follow the example to protect the public and prevent conflicts of interest," Goshen said. One of the main problems in Israel, according to Goshen, is that 90 percent of publicly traded companies have a controlling entity that holds more than 50% of the shares - a situation that curbs competition and limits decisions. As such, one of the committee's recommendations seeks to require approval from a majority of shareholders for corporate deals rather than the one-third required until now. The committee also recommends enlarging the number of external directors to at least one-third of the board. Under the Israeli Act, companies incorporated in Israel whose shares are publicly held in or outside of Israel are required to appoint at least two external directors. For reasons of potential conflict of interest, the committee proposes the strict separation of chairman of the board and chief executive officer with the former not holding any other position within the company. Both chairman and CEO would have to take corporate responsibility for financial reports by personally signing off on the appropriateness of the company's financial statements - the equivalent of the Sarbanes-Oxley Act 302 - the mandatory US corporate governance code.



More about:Enron

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS